Insulet Corporation

(PODD) Trade

By |

Profile

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and a wireless personal diabetes manager that controls the dosage and has an integrated blood glucose meter. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 140,000-145,000 insulin-dependent diabetics are using it worldwide.

Contact Information

Website: www.insulet.com
Email: dgordon@insulet.com
Main Phone: +1 978 600-7000
Address: 100 Nagog Park
Address 2: Suite 200
State: MA
City / Town: Acton
Country: US
Postal Code: 01720

Issuer Information

Exchange: NGS
CEO: Shacey Petrovic
Employees: 1350
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

Profile

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and a wireless personal diabetes manager that controls the dosage and has an integrated blood glucose meter. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 140,000-145,000 insulin-dependent diabetics are using it worldwide.

Contact Information

Website: www.insulet.com
Email: dgordon@insulet.com
Main Phone: +1 978 600-7000
Address: 100 Nagog Park
Address 2: Suite 200
State: MA
City / Town: Acton
Country: US
Postal Code: 01720

Issuer Information

Exchange: NGS
CEO: Shacey Petrovic
Employees: 1350
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

$ 225.02 $ 1.30 (0.58%)
Last Price 225.02 Change $ 1.30 Change % 0.58 Tick N/A
Bid 180.00 Bid Size 100.00 Ask 248.48 Ask Size 100.00
Open 226.17 High 233.00 Low 223.19 Prev Close 223.72
Last Trade Volume 1.5 mi 52 Wk Hi 234.00 52 Wk Low 121.00
Market Cap 14.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 65,650,528.00 EPS (TTM) 0.28 PE Ratio 803.60 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 33 98
Number of Buys 14 39
Number of Sells 19 59
Net Activity -21594 187800
Last 10 Buys Shares
James C. Mullen 1,000
Charles Alpuche 1,000
Michael P. Spears 1,000
Jessica Hopfield 1,000
Brad Thomas 1,000
Charles Alpuche 1,000
Patrick J. Sullivan 1,000
Brad Thomas 1,000
Patrick J. Sullivan 1,000
Patrick J. Sullivan 1,000
Last 10 Sell Shares
Michael P. Spears 1,000
Michael P. Spears 1,000
Shacey Petrovic 1,000
Michael P. Spears 1,000
Michael P. Spears 1,000
Michael P. Spears 1,000
Michael P. Spears 1,000
David Colleran 1,000
Michael P. Spears 1,000
Michael P. Spears 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 106 106 105 106
Low Target Price Estimate 81 81 81 81
Mean Target Price Estimate 97.44 97.44 95.88 97.44
Standard Deviation 7.05 7.05 7.28 7.05
Date of Most Recent Estimate 06/04/18 06/04/18 05/25/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 12 12 13 11
Moderate Buy 1 1 1 1
Hold 6 6 5 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.68 1.68 1.58 1.72